Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 37
1.
J Nutr Biochem ; 127: 109602, 2024 May.
Article En | MEDLINE | ID: mdl-38373509

This study evaluated the effect of vitamin D3 (VIT D3) supplementation on the enzymatic activities and density of ectonucleoside triphosphate diphosphohydrolase (E-NTPDase), ecto-5-nucleotidase (E-5'-NT), adenosine deaminase (ADA), as well as the density of P2 × 7R, P2Y12R, A1R, A2AR receptors, IL-1ß, and oxidative parameters in type 2 diabetic rats. Forty male Wistar rats were fed a high carbohydrate-high fat diet (HCHFD) and received an intraperitoneal injection containing a single dose of streptozotocin (STZ, 35 mg/kg). Animals were divided into four groups: 1) control; 2) control/VIT D3 12 µg/kg; 3) diabetic; and 4) diabetic/VIT D3 12 µg/kg. Results show that VIT D3 reduced blood glucose, ATP hydrolysis, ADA activity, P2Y12R density (platelets), as well as ATP, ADP, and AMP hydrolysis and ADA activity (synaptosomes). Moreover, VIT D3 increased insulin levels and AMP hydrolysis (platelets) and improved antioxidant defense. Therefore, we suggest that VIT D3 treatment modulates hyperglycemia-induced changes via purinergic enzymes and receptor expression, consequently attenuating insulin homeostasis dysregulation in the diabetic state.


Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Insulins , Rats , Male , Animals , Rats, Wistar , Cholecalciferol/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/drug therapy , Diet, High-Fat/adverse effects , Vitamins , Adenosine Monophosphate/metabolism , Adenosine Triphosphate/metabolism
2.
J Nutr Biochem ; 115: 109280, 2023 05.
Article En | MEDLINE | ID: mdl-36796549

The present study evaluated the effect of caffeic acid (CA) on behavioral learning and memory tasks in the diabetic state. We also evaluated the effect of this phenolic acid on the enzymatic activities of acetylcholinesterase, ecto-nucleoside triphosphate diphosphohydrolase, ecto-5-nucleotidase and adenosine deaminase as well as on the density of M1R, α7nAChR, P2×7R, A1R, A2AR, and inflammatory parameters in the cortex and hippocampus of diabetic rats. Diabetes was induced by a single intraperitoneal dose of streptozotocin (55 mg/kg). The animals were divided into six groups: control/vehicle; control/CA 10 and 50 mg/kg; diabetic/vehicle; diabetic/CA 10 and 50 mg/kg, treated by gavage. The results showed that CA improved learning and memory deficits in diabetic rats. Also, CA reversed the increase in acetylcholinesterase and adenosine deaminase activities and reduced ATP and ADP hydrolysis. Moreover, CA increased the density of M1R, α7nAChR, and A1R receptors and reversed the increase in P2×7R and A2AR density in both evaluated structures. In addition, CA treatment attenuated the increase in NLRP3, caspase 1, and interleukin 1ß density in the diabetic state; moreover, it increased the density of interleukin-10 in the diabetic/CA 10 mg/kg group. The results indicated that CA treatment positively modified the activities of cholinergic and purinergic enzymes and the density of receptors, and improved the inflammatory parameters of diabetic animals. Thus, the outcomes suggest that this phenolic acid could improve the cognitive deficit linked to cholinergic and purinergic signaling in the diabetic state.


Cognitive Dysfunction , Diabetes Mellitus, Experimental , Rats , Animals , Rats, Wistar , Adenosine Deaminase/metabolism , Acetylcholinesterase/metabolism , Streptozocin , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/drug therapy , Neuroinflammatory Diseases , alpha7 Nicotinic Acetylcholine Receptor/metabolism , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/etiology , Signal Transduction , Cholinergic Agents/therapeutic use
3.
Mol Cell Endocrinol ; 563: 111852, 2023 03 01.
Article En | MEDLINE | ID: mdl-36657632

Several studies have indicated the vitamin D deficiency in the development of macro- and microvascular complications of diabetes mellitus (DM) including DM-related cognitive dysfunction. The purinergic system plays an important role in the modulation of a variety of mechanisms, including neuroinflammation, plasticity, and cell-cell communication. In addition, purines, their receptors, and enzymes can regulate the purinergic axis at different levels in type 1 DM (T1DM). This study evaluated the effects of vitamin D3 alone or in combination with metformin in the behavioral performance of streptozotocin-induced T1DM rats. The effects of this combination on the metabolism of ATP and ADP were also studied by NTPDase (CD39), AMP by 5'-nucleotidase (CD73), and adenosine by adenosine deaminase (E-ADA) in the brain and peripheral lymphocytes of type 1 diabetic STZ-induced rats. The results showed that anxiety and memory loss from the DM condition reverted after 30 days of vitamin D3 treatment. Furthermore, the DM state affected systemic enzymes, with no effect on the central enzymes hydrolyzing extracellular nucleotides and nucleosides. Vitamin D3 treatment positively regulated ectonucleotidase (NTPDase and 5'-nucleotidase) activity, E-ADA, and the purinergic receptors as a mechanism to prevent oxidative damage in the cerebral cortex of T1DM rats. A neuroprotector effect of vitamin D3 through adenosine signaling was also observed, by regulating A1 and A2A receptors proteins levels. The present findings suggest that purinergic signaling through vitamin D3 modulation may be a novel alternative strategy for T1DM treatment, and may compensate for the negative changes in the central nervous system.


Diabetes Mellitus, Type 1 , Metformin , Rats , Animals , Cholecalciferol , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/drug therapy , 5'-Nucleotidase/metabolism , Metformin/pharmacology , Adenosine/pharmacology
4.
Life Sci ; 277: 119421, 2021 Jul 15.
Article En | MEDLINE | ID: mdl-33785337

Diabetes mellitus (DM) is a metabolic disorder characterized by a chronic hyperglycemia state, increased oxidative stress parameters, and inflammatory processes. AIMS: To evaluate the effect of caffeic acid (CA) on ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) and adenosine deaminase (ADA) enzymatic activity and expression of the A2A receptor of the purinergic system, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymatic activity and expression of the α7nAChR receptor of the cholinergic system as well as inflammatory and oxidative parameters in diabetic rats. METHODS: Diabetes was induced by a single dose intraperitoneally of streptozotocin (STZ, 55 mg/kg). Animals were divided into six groups (n = 10): control/oil; control/CA 10 mg/kg; control/CA 50 mg/kg; diabetic/oil; diabetic/CA 10 mg/kg; and diabetic/CA 50 mg/kg treated for thirty days by gavage. RESULTS: CA treatment reduced ATP and ADP hydrolysis (lymphocytes) and ATP levels (serum), and reversed the increase in ADA and AChE (lymphocytes), BuChE (serum), and myeloperoxidase (MPO, plasma) activities in diabetic rats. CA treatment did not attenuate the increase in IL-1ß and IL-6 gene expression (lymphocytes) in the diabetic state; however, it increased IL-10 and A2A gene expression, regardless of the animals' condition (healthy or diabetic), and α7nAChR gene expression. Additionally, CA attenuated the increase in oxidative stress markers and reversed the decrease in antioxidant parameters of diabetic animals. CONCLUSION: Overall, our findings indicated that CA treatment positively modulated purinergic and cholinergic enzyme activities and receptor expression, and improved oxi-inflammatory parameters, thus suggesting that this phenolic acid could improve redox homeostasis dysregulation and purinergic and cholinergic signaling in the diabetic state.


Acetylcholinesterase/metabolism , Butyrylcholinesterase/metabolism , Caffeic Acids/pharmacology , Diabetes Mellitus, Experimental/pathology , Gene Expression Regulation/drug effects , Inflammation Mediators/metabolism , Oxidative Stress/drug effects , Acetylcholinesterase/genetics , Adenosine Deaminase/genetics , Adenosine Deaminase/metabolism , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Antioxidants/pharmacology , Apyrase/genetics , Apyrase/metabolism , Butyrylcholinesterase/genetics , Cytokines/metabolism , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/pathology , GPI-Linked Proteins/genetics , GPI-Linked Proteins/metabolism , Lipid Peroxidation/drug effects , Lymphocytes/drug effects , Lymphocytes/metabolism , Lymphocytes/pathology , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Peroxidase/metabolism , Rats , Rats, Wistar , alpha7 Nicotinic Acetylcholine Receptor/genetics , alpha7 Nicotinic Acetylcholine Receptor/metabolism
5.
Biomed Pharmacother ; 137: 111273, 2021 May.
Article En | MEDLINE | ID: mdl-33524787

Diabetes mellitus (DM) and hypertension are highly prevalent worldwide health problems and frequently associated with severe clinical complications, such as diabetic cardiomyopathy, nephropathy, retinopathy, neuropathy, stroke, and cardiac arrhythmia, among others. Despite all existing research results and reasonable speculations, knowledge about the role of purinergic system in individuals with DM and hypertension remains restricted. Purinergic signaling accounts for a complex network of receptors and extracellular enzymes responsible for the recognition and degradation of extracellular nucleotides and adenosine. The main components of this system that will be presented in this review are: P1 and P2 receptors and the enzymatic cascade composed by CD39 (NTPDase; with ATP and ADP as a substrate), CD73 (5'-nucleotidase; with AMP as a substrate), and adenosine deaminase (ADA; with adenosine as a substrate). The purinergic system has recently emerged as a central player in several physiopathological conditions, particularly those linked to inflammatory responses such as diabetes and hypertension. Therefore, the present review focuses on changes in both purinergic P1 and P2 receptor expression as well as the activities of CD39, CD73, and ADA in diabetes and hypertension conditions. It can be postulated that the manipulation of the purinergic axis at different levels can prevent or exacerbate the insurgency and evolution of diabetes and hypertension working as a compensatory mechanism.


Diabetes Mellitus/metabolism , Hypertension/metabolism , Purines/metabolism , Receptors, Purinergic P1/metabolism , Receptors, Purinergic P2/metabolism , 5'-Nucleotidase/metabolism , Adenosine Deaminase/metabolism , Animals , Antigens, CD/metabolism , Apyrase/metabolism , Cell Communication , Diabetes Mellitus/epidemiology , Diabetes Mellitus/physiopathology , Diabetes Mellitus/therapy , Diet, Healthy , Exercise , Humans , Hypertension/epidemiology , Hypertension/physiopathology , Hypertension/therapy , Purinergic P1 Receptor Antagonists/therapeutic use , Purinergic P2 Receptor Antagonists/therapeutic use , Signal Transduction
6.
Mol Biol Rep ; 46(2): 2085-2092, 2019 Apr.
Article En | MEDLINE | ID: mdl-30719606

Cutaneous melanoma (CM) is an extremely aggressive cancer presenting low survival and high mortality. The vast majority of patients affected by this disease does not respond or show resistance to the chemotherapeutic drugs, which makes the treatment ineffective. In this sense, the necessity for the development of new agents to assist in CM therapy is extremely important. One of the sources of great interest in this search are compounds of natural origin. Among these compounds, caffeic acid has demonstrated a broad spectrum of pharmacological activities as well as antitumor effects in some types of cancer. Therefore, the objective of this work was to investigate the possible antitumor effect of caffeic acid on the SK-Mel-28 cell line, human CM cells. Cells were cultured in flasks with culture medium containing fetal bovine serum, antibiotic, and antifungal, and maintained in ideal conditions. Cells were treated with 25 µM, 50 µM, 100 µM, 150 µM and 200 µM of caffeic acid and dacarbazine at 1 mg/mL. We verified the effect on cell viability and cell death, apoptosis, cell cycle, colony formation and gene expression of caspases. Results showed a decrease in cell viability, cell death induction by apoptosis, inhibition of colony formation, modulation of cell cycle and alterations in gene expression of caspases after caffeic acid treatment. These results suggest an antitumor effect of the compound on SK-Mel-28 cells. This study provides original information on mechanisms by which caffeic acid may play a key role in preventing tumor progression in human melanoma cells.


Caffeic Acids/pharmacology , Melanoma/drug therapy , Adult , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Caffeic Acids/metabolism , Caspases/drug effects , Caspases/genetics , Cell Cycle/drug effects , Cell Cycle Proteins/drug effects , Cell Cycle Proteins/genetics , Cell Division/drug effects , Cell Line, Tumor/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Dacarbazine/pharmacology , Female , Healthy Volunteers , Humans , Male , Melanoma/pathology , Skin Neoplasms/drug therapy , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Melanoma, Cutaneous Malignant
7.
J Cell Biochem ; 120(3): 3232-3242, 2019 03.
Article En | MEDLINE | ID: mdl-30230598

Sepsis is a generalized infection that involves alterations in inflammatory parameters, oxidant status, and purinergic signaling in many tissues. Physical exercise has emerged as a tool to prevent this disease because of its anti-inflammatory and antioxidant properties. Thus, in this study, we investigated the effects of physical exercise on preventing alterations in purinergic system components, oxidative stress, and inflammatory parameters in lipopolysaccharide (LPS)-induced sepsis in rats. Male Wistar rats were divided into four groups: control, exercise (EX), LPS, and EX+LPS. The resisted physical exercise was performed for 12 weeks on a ladder with 1 m height. After 72 hours of the last exercise session, the animals received 2.5 mg/kg of LPS for induction of sepsis, and after 24 hours, lungs and blood samples were collected for analysis. The results showed that the exercise protocol used was able to prevent, in septic animals: (1) the increase in body temperature; (2) the increase of lipid peroxidation and reactive species levels in the lung, (3) the increase in adenosine triphosphate levels in serum; (4) the change in the activity of the enzymes ectonucleotidases in lymphocytes, partially; (5) the change in the density of purinergic enzymes and receptors in the lung, and (6) the increase of IL-6 and IL-1ß gene expression. Our results revealed the involvement of purinergic signaling and oxidative damage in the mechanisms by which exercise prevents sepsis aggravations. Therefore, the regular practice of physical exercise is encouraged as a better way to prepare the body against sepsis complications.


Lipopolysaccharides/toxicity , Physical Conditioning, Animal/physiology , Sepsis/chemically induced , Sepsis/prevention & control , Animals , Antioxidants/metabolism , Catalase/metabolism , Lipid Peroxidation/drug effects , Lung/drug effects , Lung/metabolism , Male , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar , Sepsis/metabolism , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolism
8.
Food Chem Toxicol ; 123: 298-313, 2019 Jan.
Article En | MEDLINE | ID: mdl-30291944

Coffee is a drink prepared from roasted coffee beans and is lauded for its aroma and flavour. It is the third most popular beverage in the world. This beverage is known by its stimulant effect associated with the presence of methylxanthines. Caffeine, a purine-like molecule (1,3,7 trymetylxantine), is the most important bioactive compound in coffee, among others such as chlorogenic acid (CGA), diterpenes, and trigonelline. CGA is a phenolic acid with biological properties as antioxidant, anti-inflammatory, neuroprotector, hypolipidemic, and hypoglicemic. Purinergic system plays a key role inneuromodulation and homeostasis. Extracellular ATP, other nucleotides and adenosine are signalling molecules that act through their specific receptors, namely purinoceptors, P1 for nucleosides and P2 for nucleotides. They regulate many pathological processes, since adenosine, for instance, can limit the damage caused by ATP in the excitotoxicity from the neuronal cells. The primary purpose of this review is to discuss the effects of coffee, caffeine, and CGA on the purinergic system. This review focuses on the relationship/interplay between coffee, caffeine, CGA, and adenosine, and their effects on ectonucleotidases activities as well as on the modulation of P1 and P2 receptors from central nervous system and also in peripheral tissue.


Caffeine/metabolism , Chlorogenic Acid/metabolism , Plant Extracts/metabolism , Purines/metabolism , Animals , Caffeine/chemistry , Chlorogenic Acid/chemistry , Coffea/chemistry , Coffee/chemistry , Coffee/metabolism , Humans , Plant Extracts/chemistry , Receptors, Purinergic P1/genetics , Receptors, Purinergic P1/metabolism , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2/metabolism , Signal Transduction
9.
Biomed Pharmacother ; 108: 1731-1738, 2018 Dec.
Article En | MEDLINE | ID: mdl-30372876

This study evaluated the effects of caffeine in combination with high-intensity interval training (HIIT) on sensitivity to glucocorticoids and proliferation of lymphocytes, IL-6 and IL-10 levels and NTPDase, adenosine deaminase (ADA) and acetylcholinesterase (AChE) activity in rat lymphocytes. The animals were divided into groups: control, caffeine 4 mg/kg, caffeine 8 mg/kg, HIIT, HIIT plus caffeine 4 mg/kg and HIIT plus caffeine 8 mg/kg. The rats were trained three times a week for 6 weeks for a total workload 23% of body weight at the end of the experiment. Caffeine was administered orally 30 min before the training session. When lymphocytes were stimulated with phytohaemagglutinin no changes were observed in proliferative response between trained and sedentary animals; however, when caffeine was associated with HIIT an increase in T lymphocyte proliferation and in the sensitivity of lymphocytes to glucocorticoids occurred. ATP and ADP hydrolysis was decreased in the lymphocytes of the animals only trained and caffeine treatment prevented alterations in ATP hydrolysis. HIIT caused an increase in the ADA and AChE activity in lymphocytes and this effect was more pronounced in rats trained and supplemented with caffeine. The level of IL-6 was increased while the level of IL-10 was decreased in trained animals (HIIT) and caffeine was capable of preventing this exercise effect. Our findings suggest that caffeine ingestion attenuates, as least in part, the immune and inflammatory alterations following a prolonged HIIT protocol.


Caffeine/pharmacology , Cytokines/metabolism , Lymphocytes/metabolism , Physical Conditioning, Animal , Receptors, Cholinergic/metabolism , Receptors, Purinergic/metabolism , Signal Transduction , Acetylcholinesterase/metabolism , Adenosine/metabolism , Adenosine Deaminase/metabolism , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Cell Proliferation/drug effects , Cytokines/blood , Glucocorticoids/pharmacology , Hydrolysis , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Male , Rats, Wistar , Signal Transduction/drug effects
10.
Mol Nutr Food Res ; 62(16): e1800050, 2018 08.
Article En | MEDLINE | ID: mdl-29888863

SCOPE: Beneficial effects produced by polyphenolic compounds are used in the treatment of various diseases, including diabetes. Thus it is relevant to investigate the protective effect of lingonberry extract (LB) on the activities of nucleoside triphosphate diphosphohydrolase (NTPDase), 5'-nucleotidase (5'-NT), and adenosine deaminase (ADA); the density of A1, A2A, and P2×7 receptors; production of reactive species (RS); and the levels of thiobarbituric acid reactive substances (TBARS) in the cerebral cortex of streptozotocin-induced diabetic rats. METHODS AND RESULTS: Animals were divided into five groups (n = 10): control/saline; control/LB 50 mg kg-1 ; diabetic/saline; diabetic/LB 25 mg kg-1 ; and diabetic/LB 50 mg kg-1 ; and treated for 30 days. Our results demonstrate that the treatment with LB increased NTPDase activity in the diabetic/LB 50 group compared to diabetic/saline group. Western blot analysis showed that LB restored the density of purinergic receptors to the approximate values of the control/saline group. An increase in the levels of RS and TBARS was observed in the diabetic/saline group compared with the control/saline group, and treatment with LB can prevent this increase. CONCLUSION: This study showed that LB could reverse the modifications found in the diabetic state, suggesting that lingonberry may be a coadjuvant in the treatment of diabetes.


Aminohydrolases/metabolism , Diabetes Mellitus, Experimental/drug therapy , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Receptors, Purinergic/drug effects , Vaccinium vitis-idaea , 5'-Nucleotidase/metabolism , Animals , Blood Glucose/analysis , Cerebral Cortex/metabolism , Diabetes Mellitus, Experimental/metabolism , Male , Rats , Rats, Wistar , Streptozocin
11.
Nutr Res ; 55: 45-56, 2018 07.
Article En | MEDLINE | ID: mdl-29914627

Quercetin is reported to exert a plethora of health benefits through many different mechanisms of action. This versatility and presence in the human diet has attracted the attention of the scientific community, resulting in a huge output of in vitro and in vivo (preclinical) studies. Therefore, we hypothesized that quercetin can protect Na+,K+-ATPase activity in the central nervous system, reestablish the peripheral cholinesterases activities, and reduce oxidative stress during demyelination events in rats. In line with this expectation, our study aims to find out how quercetin acts on the Na+,K+-ATPase activity in the central nervous system, peripheral cholinesterases, and stress oxidative markers in an experimental model of demyelinating disease. Wistar rats were divided into 4 groups: vehicle, quercetin, ethidium bromide (EB), and EB plus quercetin groups. The animals were treated once a day with vehicle (ethanol 20%) or quercetin 50 mg/kg for 7 (demyelination phase, by gavage) or 21 days (remyelination phase) after EB (0.1%, 10 µL) injection (intrapontine).The encephalon was removed, and the pons, hypothalamus, cerebral cortex, hippocampus, striatum, and cerebellum were dissected to verify the Na+,K+-ATPase activity. Our results showed that quercetin protected against reduction in Na+,K+-ATPase in the pons and cerebellum in the demyelination phase, and it increased the activity of this enzyme in the remyelination phase. During the demyelination, quercetin promoted the increase in acetylcholinesterase activity in whole blood and lymphocytes induced by EB, and it reduced the increase in acetylcholinesterase activity in lymphocytes in the remyelination phase. On day 7, EB increased the superoxide dismutase and decreased catalase activities, as well as increased the thiobarbituric acid-reactive substance levels. Taken together, these results indicated that quercetin regulates the Na+,K+-ATPase activity, affects the alterations of redox state, and participates in the reestablishment of peripheral cholinergic activity during demyelinating and remyelination events.


Acetylcholinesterase/metabolism , Antioxidants/pharmacology , Demyelinating Diseases/metabolism , Oxidative Stress/drug effects , Quercetin/pharmacology , Remyelination/physiology , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Antioxidants/metabolism , Brain/drug effects , Brain/metabolism , Catalase/metabolism , Disease Models, Animal , Lymphocytes/metabolism , Male , Oxidation-Reduction , Plant Extracts/pharmacology , Rats, Wistar , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances
12.
J Nutr Biochem ; 38: 145-153, 2016 12.
Article En | MEDLINE | ID: mdl-27736734

We evaluated the effect of chlorogenic acid (CGA), caffeine (CA) and coffee (CF) on components of the purinergic system from the cerebral cortex and platelets of streptozotocin-induced diabetic rats. Animals were divided into eight groups: control animals treated with (I) water (WT), (II) CGA (5 mg/kg), (III) CA (15 mg/kg) and (IV) CF (0.5 g/kg), and diabetic animals treated with (V) WT, (VI) CGA (5 mg/kg), (VII) CA (15 mg/kg) and (VIII) CF (0.5 g/kg). Our results showed an increase (173%) in adenosine monophosphate (AMP) hydrolysis in the cerebral cortex of diabetic rats. In addition, CF treatment increased adenosine diphosphate (ADP) and AMP hydrolysis in group VIII synaptosomes. Platelets showed an increase in ectonucleotidase activity in group V, and all treatments reduced the increase in adenosine triphosphate and ADP hydrolysis. Furthermore, there was an increase in platelet aggregation of 72% in the diabetic rats, and CGA and CF treatment reduced platelet aggregation by nearly 60% when compared to diabetic rats. In this context, we can suggest that CGA and CF treatment should be considered a therapeutic and scientific target to be investigated in diseases associated with hyperglycemia.


Caffeine/therapeutic use , Cerebral Cortex/metabolism , Chlorogenic Acid/therapeutic use , Diabetes Mellitus, Experimental/diet therapy , Diabetic Neuropathies/prevention & control , Dietary Supplements , Neuroprotective Agents/therapeutic use , 5'-Nucleotidase/antagonists & inhibitors , 5'-Nucleotidase/genetics , 5'-Nucleotidase/metabolism , Adenine Nucleotides/metabolism , Animals , Blood Platelets/enzymology , Blood Platelets/metabolism , Cerebral Cortex/enzymology , Coffee , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , GPI-Linked Proteins/antagonists & inhibitors , GPI-Linked Proteins/genetics , GPI-Linked Proteins/metabolism , Gene Expression Regulation, Enzymologic , Hydrolysis , Male , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/enzymology , Neurons/metabolism , Neuroprotection , Platelet Aggregation , Purinergic Agents/therapeutic use , Rats, Wistar , Synaptosomes/enzymology , Synaptosomes/metabolism
13.
Biomed Pharmacother ; 84: 559-568, 2016 Dec.
Article En | MEDLINE | ID: mdl-27694000

The present study investigated the protective effect of quercetin (Querc) on memory, anxiety-like behavior and impairment of ectonucleotidases and acetylcholinesterase (AChE) activities in brain of streptozotocin-induced diabetic rats (STZ-diabetes). The type 1 diabetes mellitus was induced by an intraperitoneal injection of 70mg/kg of streptozotocin (STZ), diluted in 0.1M sodium-citrate buffer (pH 4.5). Querc was dissolved in 25% ethanol and administered by gavage at the doses of 5, 25 and 50mg/kg once a day during 40days. The animals were distributed in eight groups of ten animals as follows: vehicle, Querc 5mg/kg, Querc 25mg/kg, Querc 50mg/kg, diabetes, diabetes plus Querc 5mg/kg, diabetes plus Querc 25mg/kg and diabetes plus Querc 50mg/kg. Querc was able to prevent the impairment of memory and the anxiogenic-like behavior induced by STZ-diabetes. In addition, Querc prevents the decrease in the NTPDase and increase in the adenosine deaminase (ADA) activities in SN from cerebral cortex of STZ-diabetes. STZ-diabetes increased the AChE activity in SN from cerebral cortex and hippocampus. Querc 50mg/kg was more effective to prevent the increase in AChE activity in the brain of STZ-diabetes. Querc also prevented an increase in the malondialdehyde levels in all the brain structures. In conclusion, the present findings showed that Querc could prevent the impairment of the enzymes that regulate the purinergic and cholinergic extracellular signaling and improve the memory and anxiety-like behavior induced by STZ-diabetes.


5'-Nucleotidase/metabolism , Acetylcholinesterase/metabolism , Adenosine Deaminase/metabolism , Anxiety/prevention & control , Behavior, Animal/drug effects , Brain/drug effects , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Memory Disorders/prevention & control , Memory/drug effects , Neuroprotective Agents/pharmacology , Quercetin/pharmacology , Animals , Anxiety/chemically induced , Anxiety/enzymology , Anxiety/psychology , Brain/enzymology , Brain/physiopathology , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/enzymology , Diabetes Mellitus, Experimental/psychology , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/enzymology , Diabetes Mellitus, Type 1/psychology , Dose-Response Relationship, Drug , GPI-Linked Proteins/metabolism , Male , Malondialdehyde/metabolism , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/enzymology , Memory Disorders/psychology , Motor Activity/drug effects , Rats, Wistar , Streptozocin
14.
Biomed Pharmacother ; 84: 1194-1201, 2016 Dec.
Article En | MEDLINE | ID: mdl-27788477

BACKGROUND: This study investigated the effects of Padauk leaf on brain malondialdehyde (MDA) content, acetylcholinesterase (AChE) activities, ectonucleotidases and adenosine deaminase (ADA) activities in the platelet of high fat diet and streptozotocin (STZ)-induced diabetic rats. METHODS: The animals were divided into six groups (n=7): normal control rats; diabetic rats+high fat diet (HFD); diabetic rats+HFD+Metformin; diabetic rats+HFD+acarbose; diabetic rats+HFD+10% Padauk leaf; normal rats+basal diet+10% Padauk leaf. After 30days of experiment comprising of acclimatization, dietary manipulation, pre-treatment with STZ and supplementation with Padauk leaf, the animals were sacrificed and the rats' brain and blood were collected for subsequent analysis. RESULTS: The results demonstrated that the elevated MDA content and AChE activity in the diabetic rats were significantly reduced when compared with the control rats. Furthermore, the increased NTPDases, 5'-nucleotidase and ADA activities in the diabetic rats were significantly reduced when compared with the control rats. CONCLUSION: This study demonstrated that Padauk leaf exhibited modulatory effects on purinergic and cholinergic enzymes involved in the prevention of platelet abnormality and consequent vascular complications in diabetic state.


Blood Platelets/pathology , Brain/pathology , Diabetes Mellitus, Experimental/drug therapy , Dietary Supplements , Plant Extracts/blood , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Pterocarpus/chemistry , 5'-Nucleotidase/metabolism , Acetylcholinesterase/metabolism , Adenosine Deaminase/metabolism , Animals , Blood Platelets/drug effects , Blood Platelets/enzymology , Brain/drug effects , Brain/enzymology , Chromatography, High Pressure Liquid , Diabetes Mellitus, Experimental/pathology , Diet, High-Fat , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Phenols/analysis , Plant Extracts/pharmacology , Rats, Wistar , Reactive Oxygen Species/metabolism , Streptozocin
15.
J. physiol. biochem ; 71(4): 743-751, dic. 2015.
Article En | IBECS | ID: ibc-145726

In the present study, we investigated the efficiency of rosmarinic acid (RA) in preventing the alteration of oxidative parameters in the liver and kidney of diabetic rats induced by streptozotocin (STZ). The animals were divided into six groups (n = 8): control, ethanol, RA 10 mg/kg, diabetic, diabetic/ethanol, and diabetic/RA 10 mg/kg. After 3 weeks of treatment, we found that TBARS levels in liver and kidney were significantly increased in the diabetic/saline group and the administration of RA prevented this increase in the liver and kidney (P < 0.05). Diabetes caused a significant decrease in the activity of superoxide dismutase (SOD) and catalase (CAT) in the diabetes/saline group (P < 0.05). However, the treatment with 10 mg/kg RA (antioxidant) prevented this alteration in SOD and CAT activity in the diabetic RA group (P < 0.05). In addition, RA reverses the decrease in ascorbic acid and non-protein-thiol (NPSH) levels in diabetic rats. The treatment with RA also prevented the decrease in the Delta-aminolevulinic acid dehydratase (ALA-D) activity in the liver and kidney of diabetic rats. Furthermore, RA did not have any effect on glycemic levels. These results indicate that RA effectively reduced the oxidative stress induced by STZ, suggesting that RA is a potential candidate for the prevention and treatment of pathological conditions in diabetic models


Animals , Rats , Diabetes Mellitus/drug therapy , Oxidative Stress , Antioxidants/pharmacokinetics , Plant Extracts/pharmacokinetics , Biomarkers/analysis , Protective Agents/pharmacokinetics , Diabetes Mellitus/physiopathology , Diabetes Mellitus, Experimental/physiopathology
16.
J Physiol Biochem ; 71(4): 743-51, 2015 Dec.
Article En | MEDLINE | ID: mdl-26452500

In the present study, we investigated the efficiency of rosmarinic acid (RA) in preventing the alteration of oxidative parameters in the liver and kidney of diabetic rats induced by streptozotocin (STZ). The animals were divided into six groups (n = 8): control, ethanol, RA 10 mg/kg, diabetic, diabetic/ethanol, and diabetic/RA 10 mg/kg. After 3 weeks of treatment, we found that TBARS levels in liver and kidney were significantly increased in the diabetic/saline group and the administration of RA prevented this increase in the liver and kidney (P < 0.05). Diabetes caused a significant decrease in the activity of superoxide dismutase (SOD) and catalase (CAT) in the diabetes/saline group (P < 0.05). However, the treatment with 10 mg/kg RA (antioxidant) prevented this alteration in SOD and CAT activity in the diabetic RA group (P < 0.05). In addition, RA reverses the decrease in ascorbic acid and non-protein-thiol (NPSH) levels in diabetic rats. The treatment with RA also prevented the decrease in the Delta-aminolevulinic acid dehydratase (ALA-D) activity in the liver and kidney of diabetic rats. Furthermore, RA did not have any effect on glycemic levels. These results indicate that RA effectively reduced the oxidative stress induced by STZ, suggesting that RA is a potential candidate for the prevention and treatment of pathological conditions in diabetic models.


Antioxidants/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Kidney/metabolism , Liver/metabolism , Animals , Antioxidants/therapeutic use , Ascorbic Acid/metabolism , Biomarkers/metabolism , Blood Glucose , Cinnamates/therapeutic use , Depsides/therapeutic use , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Drug Evaluation, Preclinical , Kidney/drug effects , Liver/drug effects , Male , Malondialdehyde/metabolism , Oxidative Stress , Rats, Wistar , Streptozocin , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Rosmarinic Acid
17.
J. physiol. biochem ; 70(2): 487-496, jun. 2014.
Article En | IBECS | ID: ibc-122969

The aim of this study was to assess whether alfa-tocopherol administration prevented alterations in the ectonucleotidase activities and platelet aggregation induced by high-fat diet in rats. Thus, we examined four groups of male rats which received standard diet, high-fat diet (HFD), α-tocopherol (α-Toc), and high-fat diet plus α-tocopherol. HFD was administered ad libitum and α-Toc by gavage using a dose of 50 mg/kg. After 3 months of treatment, animals were submitted to euthanasia, and blood samples were collected for biochemical assays. Results demonstrate that NTPDase, ectonucleotide pyrophosphatase/phosphodiesterase, and 5'-nucleotidase activities were significantly decreased in platelets of HFD group, while that adenosine deaminase (ADA) activity was significantly increased in this group in comparison to the other groups (P < 0.05). When rats that received HFD were treated with α-Toc, the activities of these enzymes were similar to the control, but ADA activity was significantly increased in relation to the control and α-Toc group (P < 0.05). HFD group showed an increased in platelet aggregation in comparison to the other groups, and treatment with α-Toc significantly reduced platelet aggregation in this group. These findings demonstrated that HFD alters platelet aggregation and purinergic signaling in the platelets and that treatment with α-Toc was capable of modulating the adenine nucleotide hydrolysis in this experimental condition


No disponible


Animals , Rats , Cyclic AMP Receptor Protein , Nucleotides/physiology , Platelet Aggregation , alpha-Tocopherol/pharmacokinetics , Dietary Fats/metabolism , Receptors, Purinergic , Adenine Nucleotides/physiology , Disease Models, Animal
18.
J Physiol Biochem ; 70(2): 487-96, 2014 Jun.
Article En | MEDLINE | ID: mdl-24623516

The aim of this study was to assess whether α-tocopherol administration prevented alterations in the ectonucleotidase activities and platelet aggregation induced by high-fat diet in rats. Thus, we examined four groups of male rats which received standard diet, high-fat diet (HFD), α-tocopherol (α-Toc), and high-fat diet plus α-tocopherol. HFD was administered ad libitum and α-Toc by gavage using a dose of 50 mg/kg. After 3 months of treatment, animals were submitted to euthanasia, and blood samples were collected for biochemical assays. Results demonstrate that NTPDase, ectonucleotide pyrophosphatase/phosphodiesterase, and 5'-nucleotidase activities were significantly decreased in platelets of HFD group, while that adenosine deaminase (ADA) activity was significantly increased in this group in comparison to the other groups (P < 0.05). When rats that received HFD were treated with α-Toc, the activities of these enzymes were similar to the control, but ADA activity was significantly increased in relation to the control and α-Toc group (P < 0.05). HFD group showed an increased in platelet aggregation in comparison to the other groups, and treatment with α-Toc significantly reduced platelet aggregation in this group. These findings demonstrated that HFD alters platelet aggregation and purinergic signaling in the platelets and that treatment with α-Toc was capable of modulating the adenine nucleotide hydrolysis in this experimental condition.


Diet, High-Fat , Nucleotides/metabolism , Platelet Aggregation , alpha-Tocopherol/pharmacology , Animals , Rats
19.
Mol Cell Biochem ; 388(1-2): 277-86, 2014 Mar.
Article En | MEDLINE | ID: mdl-24370728

Diabetes mellitus (DM) is associated with brain alterations that may contribute to cognitive dysfunctions. Chlorogenic acid (CGA) and caffeine (CA), abundant in coffee (CF), are natural compounds that have showed important actions in the brain. The present study aimed to evaluate the effect of CGA, CA, and CF on acetylcholinesterase (AChE), Na(+), K(+)-ATPase, aminolevulinate dehydratase (δ-ALA-D) activities and TBARS levels from cerebral cortex, as well as memory and anxiety in streptozotocin-induced diabetic rats. Animals were divided into eight groups (n = 5-10): control; control/CGA 5 mg/kg; control/CA 15 mg/kg; control/CF 0.5 g/kg; diabetic; diabetic/CGA 5 mg/kg; diabetic/CA 15 mg/kg; and diabetic/CF 0.5 g/kg. Our results demonstrated an increase in AChE activity and TBARS levels in cerebral cortex, while δ-ALA-D and Na(+), K(+)-ATPase activities were decreased in the diabetic rats when compared to control water group. Furthermore, a memory deficit and an increase in anxiety in diabetic rats were observed. The treatment with CGA and CA prevented the increase in AChE activity in diabetic rats when compared to the diabetic water group. CGA, CA, and CF intake partially prevented cerebral δ-ALA-D and Na(+), K(+)-ATPase activity decrease due to diabetes. Moreover, CGA prevented diabetes-induced TBARS production, improved memory, and decreased anxiety. In conclusion, among the compounds studied CGA proved to be a compound which acts better in the prevention of brain disorders promoted by DM.


Behavior, Animal/drug effects , Caffeine/pharmacology , Chlorogenic Acid/pharmacology , Coffee , Diabetes Mellitus, Experimental/drug therapy , Acetylcholinesterase/biosynthesis , Animals , Anxiety/drug therapy , Body Weight/drug effects , Cerebral Cortex/metabolism , Male , Memory/drug effects , Memory Disorders/drug therapy , Porphobilinogen Synthase/biosynthesis , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/biosynthesis , Streptozocin , Thiobarbituric Acid Reactive Substances/metabolism
20.
Cell Biochem Funct ; 32(3): 287-93, 2014 Apr.
Article En | MEDLINE | ID: mdl-24301255

We investigated the efficacy of rosmarinic acid (RA) in preventing lipid peroxidation and increased activity of acetylcholinesterase (AChE) in the brain of streptozotocin-induced diabetic rats. The animals were divided into six groups (n = 8): control, ethanol, RA 10 mg/kg, diabetic, diabetic/ethanol and diabetic/RA 10 mg/kg. After 21 days of treatment with RA, the cerebral structures (striatum, cortex and hippocampus) were removed for experimental assays. The results demonstrated that the treatment with RA (10 mg/kg) significantly reduced the level of lipid peroxidation in hippocampus (28%), cortex (38%) and striatum (47%) of diabetic rats when compared with the control. In addition, it was found that hyperglycaemia caused significant increased in the activity of AChE in hippocampus (58%), cortex (46%) and striatum (30%) in comparison with the control. On the other hand, the treatment with RA reversed this effect to the level of control after 3 weeks. In conclusion, the present findings showed that treatment with RA prevents the lipid peroxidation and consequently the increase in AChE activity in diabetic rats, demonstrating that this compound can modulate cholinergic neurotransmission and prevent damage oxidative in brain in the diabetic state. Thus, we can suggest that RA could be a promising compound in the complementary therapy in diabetes.


Acetylcholinesterase/metabolism , Antioxidants/pharmacology , Brain/metabolism , Cinnamates/pharmacology , Depsides/pharmacology , Diabetes Mellitus, Experimental/metabolism , Lipid Peroxidation/drug effects , Animals , Diabetes Mellitus, Experimental/chemically induced , Male , Rats , Rats, Wistar , Streptozocin , Rosmarinic Acid
...